Brouwinkind Pharmalab Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 29-06-2024
- Paid Up Capital ₹ 1.00 M
as on 29-06-2024
- Company Age 16 Year, 19 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 35.00 M
as on 29-06-2024
- Revenue 86086.00%
(FY 2022)
- Profit -30.88%
(FY 2022)
- Ebitda -33.79%
(FY 2022)
- Net Worth -6.49%
(FY 2022)
- Total Assets -7.00%
(FY 2022)
About Brouwinkind Pharmalab
The Corporate was formerly known as Burroughs Wellcome Pharmalab Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 Cr.
Parkash Thirani and August Thirani serve as directors at the Company.
- CIN/LLPIN
U33110DL2008PTC183320
- Company No.
183320
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Brouwinkind Pharmalab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
August Thirani  | Director | 09-Jul-2009 | Current |
| Parkash Thirani | Director | 09-Jul-2009 | Current |
Financial Performance and Corporate Structure Insights of Brouwinkind Pharmalab.
Brouwinkind Pharmalab Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 86086% increase. The company also saw a substantial fall in profitability, with a 30.88% decrease in profit. The company's net worth dipped by a decrease of 6.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brouwinkind Pharmalab?
In 2019, Brouwinkind Pharmalab had a promoter holding of 17.50% and a public holding of 82.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 26 Aug 2009 | ₹3.50 Cr | Open |
How Many Employees Work at Brouwinkind Pharmalab?
Unlock and access historical data on people associated with Brouwinkind Pharmalab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 24, 2010, Brouwinkind Pharmalab has raised a total of ₹ 0.5 M, with the most recent deal valued at ₹ 0.5 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
